You might be interested in
Health & Biotech
Health tech Thrive Tribe serves up a new star chief exec
Health & Biotech
Recce Pharmaceuticals doses all patients in phase II skin infection trial
Health & Biotech
Stockhead TV
Tony Locantro has been a client advisor/investment manager in the stockbroking industry since 1998. He’s focused on the small cap and emerging companies with a strong interest in identifying those in the mining, biotech and industrial sectors that offer growth potential.
He also delves into the psychology of speculation and provides regular insights on a number of social media and finance related outlets.
Tony Locantro looks ahead to the Summer of Tony and two stocks in Syntara (ASX:SNT) and Bellavista Resources (ASX:BVR) who are rounding the bend into a big finish as he looks ahead to 2025.
The views, information, or opinions expressed in this video are solely those of the author and do not represent the views of Stockhead.
Stockhead has not provided, endorsed or otherwise assumed responsibility for any financial product advice contained in this article. Viewers should obtain independent advice based on their own circumstances before making any financial decisions.